Alliance Rehab - A Symbria Company Revenue and Competitors

Warrenville, IL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Alliance Rehab - A Symbria Company's estimated annual revenue is currently $305.8M per year.(i)
  • Alliance Rehab - A Symbria Company's estimated revenue per employee is $378,000

Employee Data

  • Alliance Rehab - A Symbria Company has 809 Employees.(i)
  • Alliance Rehab - A Symbria Company grew their employee count by 16% last year.

Alliance Rehab - A Symbria Company's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Chief Human Resources OfficerReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
VP Symbria RehabReveal Email/Phone
6
VP Pharmacy OperationsReveal Email/Phone
7
Director Billing ServicesReveal Email/Phone
8
Regional Director OperationsReveal Email/Phone
9
Director Business DevelopmentReveal Email/Phone
10
Director Sales and MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.8M7735%N/AN/A
#2
$10.6M4988%N/AN/A
#3
$155.6M46110%N/AN/A
#4
$9.9M460%N/AN/A
#5
$213.6M6335%N/AN/A
#6
$783.2M20725%N/AN/A
#7
$6.9M32-11%N/AN/A
#8
$10.8M504%N/AN/A
#9
$54.1M1824%N/AN/A
#10
$682.7M180610%N/AN/A
Add Company

What Is Alliance Rehab - A Symbria Company?

Symbria® delivers a symbiotic approach to pharmacy, rehab and well-being services -fueled by analytics. We help the communities we partner with and the patients they serve perform at their best through the delivery of best-in-class services, resources and tools to benefit post-acute care and senior living providers. Symbria develops focused solutions for our clients’ challenges that reduce hospital readmissions, build census, and optimize length of stay.

keywords:N/A

N/A

Total Funding

809

Number of Employees

$305.8M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$419.1M848-1%N/A
#2
$389.7M1031-2%N/A
#3
$763.9M2310-3%N/A